Skip to main content

Table 2 Comparison of stage transition specific genes

From: Exploring molecular links between lymph node invasion and cancer prognosis in human breast cancer

Analysis N-MEG01 (n=40) N-MEG12 (n=40) N-MEG23 (n=40)
  + - + - + -
MP 2.8×10-4 0.13 0.24 0.13 5.7×10-12 3.8×10-11
RLP 7.7×10-7 1.0×10-15 0.13 0.084 4.8×10-11 2.3×10-6
SVP 5.9×10-4 0.03 0.75 0.53 1.2×10-10 1.4×10-5
OVP 1.2×10-11 9.3×10-13 0.24 0.08 7.8×10-29 2.0×10-17
STM 0.042 0.14 0.97 0.30 0.043 0.035
STN 0.030 3.5×10-6 0.04 0.068 9.4×10-4 0.06
STT 1.8×10-3 2.4×10-10 0.12 0.069 5.9×10-7 0.75
STG 1.1×10-5 6.9×10-9 0.01 0.015 0.11 0.53
Overall Stage 6.6×10-8 2.3×10-20 4.2×10-3 1.4×10-3 7.0×10-8 0.15
Tumor Grade 2.1×10-16 2.9×10-22 7.2×10-6 0.48 1.1×10-42 1.7×10-58
  1. N-MEG2→3 (β=10) showed the best significance in cancer prognosis test sets. While N-MEG0→1was also significantly associated with prognosis and some stages, N-MEG1→2 showed surprisingly insignificant results. MP=prognosis of metastasis, RLP=prognosis of relapse, SVP=prognosis of survival, OVP=overall prognosis, STM=stageM, STN=stageN, STG=stageG.